Not exact matches
Collaboration with Hematology and
Bone Marrow Transplantation Unit research group
in molecular diagnostics applied to the management of patients undergoing
allogeneic SCT, especially for the detection of minimal residual disease and early relapse.
The only documented long - term complete remissions reported
in multiple myeloma patients have occurred with
allogeneic bone marrow transplantation, where a donor's blood stem cells (graft) are transplanted into the patient (host) with multiple myeloma.
In close collaboration with universities and physicians world - wide, our comprehensive investigational stem cell treatments employ well - targeted combinations of
allogeneic human umbilical cord stem cells, autologous
bone marrow stem cells, and autologous adipose stem cells for the diseases listed below.
Dr. Goodman is also involved
in collaborative efforts with the San Antonio
Bone Marrow Transplant Center to study the outcome of allogeneic bone marrow transplants following a relapse from autologous bone marrow transpla
Bone Marrow Transplant Center to study the outcome of
allogeneic bone marrow transplants following a relapse from autologous bone marrow transpla
bone marrow transplants following a relapse from autologous
bone marrow transpla
bone marrow transplants.
Board - certified
in internal medicine and medical oncology, Dr. Collins has 25 years of experience
in bone marrow transplantation and has participated
in some 2,500 autologous and
allogeneic transplants.
Horwitz et al 79 reported that donor MSC contributed to
bone remodelling after
allogeneic stem cell transplantation (SCT)
in 3 children with osteogenesis imperfecta, a rare genetic disorder of type I collagen.
In the future, outpatient blood and
bone marrow stem cell transplantation will be offered to a broader group of patients with other blood disorders and for
allogeneic transplants (transplant from non-twin donor stem cells).
Allogeneic stem cell transplantation to leukaemic patients,
in which the patient's own diseased
bone marrow is replaced by healthy donor material, is one of the best - established and most effective immunological therapies.
Patients receive one of two types of stem cell - based transplants: autologous,
in which a patient donates and receives back his / her own stem cells; or
allogeneic,
in which
bone marrow - derived stem cells come from a related or unrelated donor whose human leukocyte antigens (HLA) are genetically matched with those of a patient.
Ponatinib Extends Survival Over Transplant
in Chronic Phase CML: The results of a new study that included patients from the PACE trial and the European
Bone Marrow Transplant registry revealed that treatment with ponatinib yielded better overall survival (OS) compared with
allogeneic stem cell transplantation (allo - SCT)
in patients with chronic phase chronic myeloid leukemia (CP - CML) with a T315I mutation.